Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohort

15 Feb 2022

Abstract excerpt

The significance of fibroblast growth factor receptor 2 (FGFR2) in gastric cancer (GC) has been studied predominantly in Asian patient cohorts. Data on White patients are scarce. Here, we aimed to independently validate the expression and putative tumor biological significance of FGFR2 in a large non-Asian GC cohort. Immunohistochemistry (IHC) was performed on large-area tissue sections from 493 patients with GC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fibroblast Growth Factor Research
Share to Gastrointestinal Tumor Research and Treatment
Share to Kruppel-like factors research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35167603
DOI: 10.1371/journal.pone.0264011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohortPMID 35167603Read ↗

FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre studySemantic proximity Read ↗

FGFR2 and favorable survival outcomes in resected poorly cohesive cell gastric cancer: Analysis from FGFR2 protein overexpression and genetic variation.Semantic proximity Read ↗

FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival.Semantic proximity Read ↗

HER2 amplification in gastric cancer is a rare event restricted to the intestinal phenotype.Semantic proximity Read ↗

Differential gene expression in growth factors, epithelial mesenchymal transition and chemotaxis in the diffuse type compared with the intestinal type of gastric cancerSemantic proximity Read ↗

FGFR2 gene amplification and clinicopathological features in gastric cancerSemantic proximity Read ↗

Acquired FGFR2 mutation leads resistance to pemigatinib in a patient with FGFR2-driven Borrmann type IV gastric cancer.Semantic proximity Read ↗

Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in FGFR2-amplified gastric cancerSemantic proximity Read ↗

HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.Semantic proximity Read ↗

A study of HER2 gene amplification and protein expression in gastric cancerSemantic proximity Read ↗

Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm.Semantic proximity Read ↗

Histogenetic insights and genetic landscape of fibromatosis-like undifferentiated gastric carcinoma: a focused study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.